Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry

被引:0
|
作者
Steinmetz, H. T. [1 ]
Boettger, I [1 ]
Lathan, B. [1 ]
Sauer, A. [1 ]
Severin, K. [1 ]
Germing, U. [1 ]
Schmitz, S. [1 ]
机构
[1] Uniklin Dusseldorf, Med Klin Hamatol & Onkol, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V722
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [31] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    [J]. CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [32] Factors Associated with Early Therapy Initiation in Patients (pts) with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Louis, Chrystal U.
    Flick, E. Dawn
    Nifenecker, Melissa
    Kiselev, Pavel
    Swern, Arlene S.
    Steensma, David P.
    [J]. BLOOD, 2018, 132
  • [33] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [34] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [35] HYPERFERRITINEMIA IS ASSOCIATED WITH IMPAIRED SURVIVAL IN PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES RESULTS FROM THE FIRST POLISH MDS REGISTRY
    Waszczuk-Gajda, A.
    Dwilewicz-Trojaczek, J.
    Madry, K.
    Drozd-Sokolowska, J.
    Stella-Holowiecka, B.
    Machowicz, R.
    Mital, A.
    Obara, A.
    Szmigielska-Kaplon, A.
    Sikorska, A.
    Kolkowska-Lesniak, A.
    Subocz, E.
    Mendrek, W.
    Szczepanska, M.
    Biedron, M.
    Jachalska, A.
    Wasilewska, E.
    Wojciechowska, M.
    Guzicka-Kazmierczak, R.
    Wiater, E.
    Kopacz, A.
    Katinas, K.
    Kruger, W.
    Dawidowska, A.
    Zawirska, D.
    Salamanczuk, Z.
    Swiderska, A.
    Gornik, S.
    Sedzimirska, M.
    Soroka-Wojtaszko, M.
    Nowicki, A.
    Jedrzejczak, W. W.
    [J]. HAEMATOLOGICA, 2015, 100 : 722 - 722
  • [36] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [37] Thrombocytopenia Predicts for Poor Survival In Patients with Lower Risk Myelodysplastic Syndromes (MDS)
    Cruz, Raymond
    Galili, Naomi
    Khan, Ghulam Sajjad
    Raza, Azra
    [J]. BLOOD, 2010, 116 (21) : 1638 - 1638
  • [38] Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
    Kasprzak, Annika
    Andresen, Julia
    Nachtkamp, Kathrin
    Kuendgen, Andrea
    Schulz, Felicitas
    Strupp, Corinna
    Kobbe, Guido
    Mackenzie, Colin
    Timm, Joerg
    Dietrich, Sascha
    Gattermann, Norbert
    Germing, Ulrich
    [J]. CANCERS, 2024, 16 (04)
  • [39] LENALIDOMIDE TREATMENT IN 20 PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS). MULTICENTER REGISTRY
    Arrizabalaga, B.
    Del Orbe, R.
    Zamora, M.
    Ardanaz, M.
    Arguinano, J.
    Sirvent, M.
    Atucha, L.
    Atucha, J.
    Insunza, A.
    Montes, C.
    Campeny, A.
    [J]. HAEMATOLOGICA, 2013, 98 : 585 - 585
  • [40] Guideline for the treatment of myelodysplastic syndromes (MDS) in South Africa
    Louw, V. J.
    Bassa, F.
    Chan, S. W.
    Dreosti, L.
    du Toit, M.
    Ferreira, M.
    Gartrell, K.
    Gunther, K.
    Jogessar, V.
    Littleton, N.
    Mahlangu, J.
    McDonald, A.
    Patel, M.
    Pool, R.
    Ruff, P.
    Schmidt, A.
    Sissolak, G.
    Swart, A.
    Verburgh, E.
    Webb, M. J.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (12): : 900 - 906